Kahn Brothers Group Inc. purchased a new position in Haleon PLC Sponsored ADR (NYSE:HLN – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 58,341 shares of the company’s stock, valued at approximately $544,000.
Several other institutional investors and hedge funds have also made changes to their positions in the stock. Western Wealth Management LLC purchased a new stake in Haleon during the 1st quarter worth about $29,000. Parkside Financial Bank & Trust lifted its holdings in Haleon by 101.3% in the 4th quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock valued at $29,000 after purchasing an additional 1,433 shares in the last quarter. Annis Gardner Whiting Capital Advisors LLC lifted its holdings in Haleon by 402.0% in the 1st quarter. Annis Gardner Whiting Capital Advisors LLC now owns 3,002 shares of the company’s stock valued at $30,000 after purchasing an additional 2,404 shares in the last quarter. Geneos Wealth Management Inc. boosted its stake in shares of Haleon by 33.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock worth $50,000 after purchasing an additional 1,203 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its stake in shares of Haleon by 428.1% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 6,321 shares of the company’s stock worth $57,000 after purchasing an additional 5,124 shares during the last quarter. 6.67% of the stock is currently owned by hedge funds and other institutional investors.
Haleon Stock Performance
NYSE:HLN opened at $10.04 on Friday. The company has a quick ratio of 0.52, a current ratio of 0.69 and a debt-to-equity ratio of 0.38. The company has a market cap of $44.24 billion, a P/E ratio of 25.76, a P/E/G ratio of 2.03 and a beta of 0.12. Haleon PLC Sponsored ADR has a fifty-two week low of $8.65 and a fifty-two week high of $11.28. The firm’s 50 day moving average is $9.77 and its two-hundred day moving average is $9.80.
Haleon Cuts Dividend
Analyst Ratings Changes
A number of equities analysts have recently weighed in on HLN shares. Rothschild & Co Redburn lowered shares of Haleon from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, June 16th. Wall Street Zen upgraded shares of Haleon from a “hold” rating to a “buy” rating in a research report on Sunday, July 12th. Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Haleon in a research note on Thursday, April 30th. Jefferies Financial Group reissued a “buy” rating on shares of Haleon in a research note on Monday. Finally, Morgan Stanley restated an “overweight” rating on shares of Haleon in a report on Thursday, August 6th. Two investment analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Haleon presently has an average rating of “Moderate Buy”.
Check Out Our Latest Analysis on Haleon
Haleon Company Profile
Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.
The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.
Read More
- Five stocks we like better than Haleon
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.
